{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:10:52Z","timestamp":1780373452035,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970885"],"award-info":[{"award-number":["31970885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141005"],"award-info":[{"award-number":["32141005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170887"],"award-info":[{"award-number":["32170887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04283-y","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:59:58Z","timestamp":1755655198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-throughput single-cell analysis reveals fully human Omp38-specific monoclonal antibodies against Acinetobacter baumannii"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","first-page":"589234","DOI":"10.3389\/fmicb.2020.589234","volume":"11","author":"SR Uppalapati","year":"2020","unstructured":"Uppalapati SR, Sett A, Pathania R. The outer membrane proteins ompa, caro, and OprD of acinetobacter baumannii confer a Two-Pronged defense in facilitating its success as a potent human pathogen. Front Microbiol. 2020;11:589234. https:\/\/doi.org\/10.3389\/fmicb.2020.589234.","journal-title":"Front Microbiol"},{"issue":"13","key":"4283_CR2","doi-asserted-by":"publisher","first-page":"e14937","DOI":"10.1097\/md.0000000000014937","volume":"98","author":"H Zhou","year":"2019","unstructured":"Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y, et al. Risk factors for acquisition and mortality of multidrug-resistant acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital. Med (Baltim). 2019;98(13):e14937. https:\/\/doi.org\/10.1097\/md.0000000000014937.","journal-title":"Med (Baltim)"},{"issue":"12","key":"4283_CR3","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","volume":"41","author":"J Garnacho-Montero","year":"2015","unstructured":"Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, et al. Task force on management and prevention of acinetobacter baumannii infections in the ICU. Intensive Care Med. 2015;41(12):2057\u201375. https:\/\/doi.org\/10.1007\/s00134-015-4079-4.","journal-title":"Intensive Care Med"},{"issue":"12","key":"4283_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939\u201351. https:\/\/doi.org\/10.1038\/nrmicro1789.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"4283_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.drudis.2019.03.002","volume":"24","author":"MJ McConnell","year":"2019","unstructured":"McConnell MJ. Where are we with monoclonal antibodies for multidrug-resistant infections? Drug Discov Today. 2019;24(5):1132\u20138. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.002.","journal-title":"Drug Discov Today"},{"issue":"1","key":"4283_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.dmpk.2018.10.003","volume":"34","author":"K Haraya","year":"2019","unstructured":"Haraya K, Tachibana T, Igawa T. Improvement of Pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metab Pharmacokinet. 2019;34(1):25\u201341. https:\/\/doi.org\/10.1016\/j.dmpk.2018.10.003.","journal-title":"Drug Metab Pharmacokinet"},{"key":"4283_CR7","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3389\/fimmu.2017.01751","volume":"8","author":"JC Almagro","year":"2017","unstructured":"Almagro JC, Daniels-Wells TR, Perez-Tapia SM, Penichet ML. Progress and challenges in the design and clinical development of antibodies for cancer therapy. Front Immunol. 2017;8:1751. https:\/\/doi.org\/10.3389\/fimmu.2017.01751.","journal-title":"Front Immunol"},{"issue":"5517","key":"4283_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G Kohler","year":"1975","unstructured":"Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495\u20137. https:\/\/doi.org\/10.1038\/256495a0.","journal-title":"Nature"},{"key":"4283_CR9","doi-asserted-by":"publisher","unstructured":"Litzow MR. Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia. Am Soc Clin Oncol Educ Book. 2013;294\u20139. https:\/\/doi.org\/10.14694\/EdBook_AM.2013.33.294.","DOI":"10.14694\/EdBook_AM.2013.33.294"},{"issue":"3","key":"4283_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","volume":"2","author":"FA Harding","year":"2010","unstructured":"Harding FA, Stickler MM, Razo J, DuBridge RB. The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs. 2010;2(3):256\u201365. https:\/\/doi.org\/10.4161\/mabs.2.3.11641.","journal-title":"MAbs"},{"issue":"1","key":"4283_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","volume":"7","author":"J Davda","year":"2019","unstructured":"Davda J, Declerck P, Hu-Lieskovan S, Hickling TP, Jacobs IA, Chou J, et al. Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics. J Immunother Cancer. 2019;7(1):105. https:\/\/doi.org\/10.1186\/s40425-019-0586-0.","journal-title":"J Immunother Cancer"},{"issue":"7\u20138","key":"4283_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1684\/bdc.2014.1949","volume":"101","author":"R Geiss","year":"2014","unstructured":"Geiss R, De La Motte Rouge T, Dubot C, Leary A, Lhomme C, Pautier P, et al. [Targeted therapy in locally and metastatic recurrent cervical cancers]. Bull Cancer. 2014;101(7\u20138):748\u201355. https:\/\/doi.org\/10.1684\/bdc.2014.1949.","journal-title":"Bull Cancer"},{"issue":"2","key":"4283_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1574884712666170809124728","volume":"13","author":"S Singh","year":"2018","unstructured":"Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, et al. Monoclonal antibodies: A review. Curr Clin Pharmacol. 2018;13(2):85\u201399. https:\/\/doi.org\/10.2174\/1574884712666170809124728.","journal-title":"Curr Clin Pharmacol"},{"key":"4283_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/02648725.2013.801235","volume":"29","author":"Y Safdari","year":"2013","unstructured":"Safdari Y, Farajnia S, Asgharzadeh M, Khalili M. Antibody humanization methods - a review and update. Biotechnol Genet Eng Rev. 2013;29:175\u201386. https:\/\/doi.org\/10.1080\/02648725.2013.801235.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-319-32805-8_3","volume":"917","author":"F Tomszak","year":"2016","unstructured":"Tomszak F, Weber S, Zantow J, Schirrmann T, Hust M, Frenzel A. Selection of Recombinant human antibodies. Adv Exp Med Biol. 2016;917:23\u201354. https:\/\/doi.org\/10.1007\/978-3-319-32805-8_3.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4283_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-018-0676-3","volume":"11","author":"Y Zou","year":"2018","unstructured":"Zou Y, Xu W, Li J. Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia. J Hematol Oncol. 2018;11(1):130. https:\/\/doi.org\/10.1186\/s13045-018-0676-3.","journal-title":"J Hematol Oncol"},{"key":"4283_CR17","doi-asserted-by":"publisher","unstructured":"Richardson E, Binter S, Kosmac M, Ghraichy M, von Niederhausern V, Kovaltsuk A, et al. Characterisation of the immune repertoire of a humanised Transgenic mouse through immunophenotyping and high-throughput sequencing. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.81629.","DOI":"10.7554\/eLife.81629"},{"issue":"1","key":"4283_CR18","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1038\/s41467-024-52357-8","volume":"15","author":"S Baker","year":"2024","unstructured":"Baker S, Krishna A, Higham S, Naydenova P, O\u2019Leary S, Scott JB, et al. Exploiting human immune repertoire Transgenic mice for protective monoclonal antibodies against antimicrobial resistant acinetobacter baumannii. Nat Commun. 2024;15(1):7979. https:\/\/doi.org\/10.1038\/s41467-024-52357-8.","journal-title":"Nat Commun"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"106473","DOI":"10.1016\/j.micpath.2023.106473","volume":"186","author":"H Barati","year":"2024","unstructured":"Barati H, Fekrirad Z, Jalali Nadoushan M, Rasooli I. Anti-OmpA antibodies as potential inhibitors of acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells. Microb Pathog. 2024;186:106473. https:\/\/doi.org\/10.1016\/j.micpath.2023.106473.","journal-title":"Microb Pathog"},{"issue":"8","key":"4283_CR20","doi-asserted-by":"publisher","first-page":"e0018723","DOI":"10.1128\/jb.00187-23","volume":"205","author":"MN Zhang","year":"2023","unstructured":"Zhang MN, Zhao XO, Cui Q, Zhu DM, Wisal MA, Yu HD, et al. Famotidine enhances rifampicin activity against acinetobacter baumannii by affecting OmpA. J Bacteriol. 2023;205(8):e0018723. https:\/\/doi.org\/10.1128\/jb.00187-23.","journal-title":"J Bacteriol"},{"key":"4283_CR21","doi-asserted-by":"publisher","first-page":"104788","DOI":"10.1016\/j.micpath.2021.104788","volume":"153","author":"Y Li","year":"2021","unstructured":"Li Y, Peng C, Zhao D, Liu L, Guo B, Shi M, et al. Outer membrane protein A inhibits the degradation of caspase-1 to regulate NLRP3 inflammasome activation and exacerbate the acinetobacter baumannii pulmonary inflammation. Microb Pathog. 2021;153:104788. https:\/\/doi.org\/10.1016\/j.micpath.2021.104788.","journal-title":"Microb Pathog"},{"issue":"1","key":"4283_CR22","doi-asserted-by":"publisher","first-page":"2437243","DOI":"10.1080\/22221751.2024.2437243","volume":"14","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Cheng H, Yu P, Wang S, Dong H, Lu S, et al. High-throughput single-cell analysis reveals Omp38-specific monoclonal antibodies that protect against acinetobacter baumannii infection. Emerg Microbes Infect. 2025;14(1):2437243. https:\/\/doi.org\/10.1080\/22221751.2024.2437243.","journal-title":"Emerg Microbes Infect"},{"key":"4283_CR23","doi-asserted-by":"publisher","first-page":"1374913","DOI":"10.3389\/fimmu.2024.1374913","volume":"15","author":"P Yu","year":"2024","unstructured":"Yu P, Ran J, Yang R, Zhu H, Lu S, Wu Y, et al. Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2. Front Immunol. 2024;15:1374913. https:\/\/doi.org\/10.3389\/fimmu.2024.1374913.","journal-title":"Front Immunol"},{"issue":"1","key":"4283_CR24","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1038\/s41467-018-05853-7","volume":"9","author":"DC Nguyen","year":"2018","unstructured":"Nguyen DC, Garimalla S, Xiao H, Kyu S, Albizua I, Galipeau J, et al. Factors of the bone marrow microniche that support human plasma cell survival and Immunoglobulin secretion. Nat Commun. 2018;9(1):3698. https:\/\/doi.org\/10.1038\/s41467-018-05853-7.","journal-title":"Nat Commun"},{"issue":"6","key":"4283_CR25","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1007\/s00203-021-02343-1","volume":"203","author":"R Hatefi Oskuei","year":"2021","unstructured":"Hatefi Oskuei R, Darvish Alipour Astaneh S, Rasooli I. A conserved region of acinetobacter trimeric autotransporter adhesion, ata, provokes suppression of acinetobacter baumannii virulence. Arch Microbiol. 2021;203(6):3483\u201393. https:\/\/doi.org\/10.1007\/s00203-021-02343-1.","journal-title":"Arch Microbiol"},{"key":"4283_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fimmu.2020.01069","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, Chen DQ, Ji L, Sun S, Jin Z, Jin ZL, et al. Development of different methods for Preparing acinetobacter baumannii outer membrane vesicles vaccine: impact of Preparation method on protective efficacy. Front Immunol. 2020;11:1069. https:\/\/doi.org\/10.3389\/fimmu.2020.01069.","journal-title":"Front Immunol"},{"issue":"7","key":"4283_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.18632\/aging.101495","volume":"10","author":"H Gu","year":"2018","unstructured":"Gu H, Liu D, Zeng X, Peng LS, Yuan Y, Chen ZF, et al. Aging exacerbates mortality of acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine. Aging. 2018;10(7):1597\u2013608. https:\/\/doi.org\/10.18632\/aging.101495.","journal-title":"Aging"},{"key":"4283_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3389\/fimmu.2020.01209","volume":"11","author":"P Bergman","year":"2020","unstructured":"Bergman P, Raqib R, Rekha RS, Agerberth B, Gudmundsson GH. Host directed therapy against infection by boosting innate immunity. Front Immunol. 2020;11:1209. https:\/\/doi.org\/10.3389\/fimmu.2020.01209.","journal-title":"Front Immunol"},{"issue":"4","key":"4283_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/21505594.2016.1150405","volume":"7","author":"R Zarrilli","year":"2016","unstructured":"Zarrilli R. Acinetobacter baumannii virulence determinants involved in biofilm growth and adherence to host epithelial cells. Virulence. 2016;7(4):367\u20138. https:\/\/doi.org\/10.1080\/21505594.2016.1150405.","journal-title":"Virulence"},{"key":"4283_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.csbj.2023.11.056","volume":"23","author":"AV Madsen","year":"2024","unstructured":"Madsen AV, Mejias-Gomez O, Pedersen LE, Preben Morth J, Kristensen P, Jenkins TP, et al. Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures. Comput Struct Biotechnol J. 2024;23:199\u2013211. https:\/\/doi.org\/10.1016\/j.csbj.2023.11.056.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"4283_CR31","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1038\/s41598-019-40461-5","volume":"9","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Kuroda D, Kiyoshi M, Nakakido M, Nagatoishi S, Soga S, et al. Exploring designability of electrostatic complementarity at an antigen-antibody interface directed by mutagenesis, biophysical analysis, and molecular dynamics simulations. Sci Rep. 2019;9(1):4482. https:\/\/doi.org\/10.1038\/s41598-019-40461-5.","journal-title":"Sci Rep"},{"issue":"5","key":"4283_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","volume":"9","author":"G Dekkers","year":"2017","unstructured":"Dekkers G, Bentlage AEH, Stegmann TC, Howie HL, Lissenberg-Thunnissen S, Zimring J, et al. Affinity of human IgG subclasses to mouse Fc gamma receptors. MAbs. 2017;9(5):767\u201373. https:\/\/doi.org\/10.1080\/19420862.2017.1323159.","journal-title":"MAbs"},{"issue":"Suppl 1","key":"4283_CR33","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1007\/s10875-012-9782-0","volume":"33","author":"A Lux","year":"2013","unstructured":"Lux A, Nimmerjahn F. Of mice and men: the need for humanized mouse models to study human IgG activity in vivo. J Clin Immunol. 2013;33(Suppl 1):S4\u20138. https:\/\/doi.org\/10.1007\/s10875-012-9782-0.","journal-title":"J Clin Immunol"},{"issue":"7","key":"4283_CR34","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.4049\/jimmunol.1200356","volume":"189","author":"MB Overdijk","year":"2012","unstructured":"Overdijk MB, Verploegen S, Ortiz Buijsse A, Vink T, Leusen JH, Bleeker WK, et al. Crosstalk between human IgG isotypes and murine effector cells. J Immunol. 2012;189(7):3430\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1200356.","journal-title":"J Immunol"},{"issue":"16","key":"4283_CR35","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1073\/pnas.1203954109","volume":"109","author":"P Smith","year":"2012","unstructured":"Smith P, DiLillo DJ, Bournazos S, Li F, Ravetch JV. Mouse model recapitulating human Fcgamma receptor structural and functional diversity. Proc Natl Acad Sci U S A. 2012;109(16):6181\u20136. https:\/\/doi.org\/10.1073\/pnas.1203954109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4283_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2):118\u201330. https:\/\/doi.org\/10.1038\/nri2017.","journal-title":"Nat Rev Immunol"},{"key":"4283_CR37","doi-asserted-by":"publisher","unstructured":"Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA. The capsular polysaccharide of acinetobacter baumannii is an obstacle for therapeutic passive immunization strategies. Infect Immun. 2017;85(12). https:\/\/doi.org\/10.1128\/IAI.00591-17.","DOI":"10.1128\/IAI.00591-17"},{"issue":"7","key":"4283_CR38","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2174\/1389450121666201023122355","volume":"22","author":"NI Bamunuarachchi","year":"2021","unstructured":"Bamunuarachchi NI, Khan F, Kim YM. Inhibition of virulence factors and biofilm formation of acinetobacter baumannii by Naturally-derived and synthetic drugs. Curr Drug Targets. 2021;22(7):734\u201359. https:\/\/doi.org\/10.2174\/1389450121666201023122355.","journal-title":"Curr Drug Targets"},{"issue":"10","key":"4283_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","volume":"10","author":"SB Halstead","year":"2010","unstructured":"Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010;10(10):712\u201322. https:\/\/doi.org\/10.1016\/S1473-3099(10)70166-3.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4283_CR40","doi-asserted-by":"publisher","first-page":"e40019","DOI":"10.1371\/journal.pone.0040019","volume":"7","author":"H Qiu","year":"2012","unstructured":"Qiu H, KuoLee R, Harris G, Van Rooijen N, Patel GB, Chen W. Role of macrophages in early host resistance to respiratory acinetobacter baumannii infection. PLoS ONE. 2012;7(6):e40019. https:\/\/doi.org\/10.1371\/journal.pone.0040019.","journal-title":"PLoS ONE"},{"issue":"1","key":"4283_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12250-011-3159-4","volume":"26","author":"P Chen","year":"2011","unstructured":"Chen P, Rayner S, Hu KH. Advances of bioinformatics tools applied in virus epitopes prediction. Virol Sin. 2011;26(1):1\u20137. https:\/\/doi.org\/10.1007\/s12250-011-3159-4.","journal-title":"Virol Sin"},{"issue":"8016","key":"4283_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w.","journal-title":"Nature"},{"issue":"10","key":"4283_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/17460441.2017.1363734","volume":"12","author":"GR Masson","year":"2017","unstructured":"Masson GR, Jenkins ML, Burke JE. An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery. Expert Opin Drug Discov. 2017;12(10):981\u201394. https:\/\/doi.org\/10.1080\/17460441.2017.1363734.","journal-title":"Expert Opin Drug Discov"},{"key":"4283_CR44","doi-asserted-by":"publisher","first-page":"859964","DOI":"10.3389\/fimmu.2022.859964","volume":"13","author":"MH Tran","year":"2022","unstructured":"Tran MH, Schoeder CT, Schey KL, Meiler J. Computational structure prediction for Antibody-Antigen complexes from Hydrogen-Deuterium exchange mass spectrometry: challenges and outlook. Front Immunol. 2022;13:859964. https:\/\/doi.org\/10.3389\/fimmu.2022.859964.","journal-title":"Front Immunol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04283-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:59:59Z","timestamp":1755655199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04283-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04283-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were conducted in strict accordance with the guidelines for the care and use of laboratory animals and were approved by the Animal Ethics and Experimental Committee of Army Medical University in Chongqing, China (Approval No. 20250017). Efforts were made to minimize animal suffering and to reduce the number of animals used in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"523"}}